Co-quetiapine 25 Mg

Co-Quetiapine 25 mg Recall Co-Quetiapine 25 mg tablets are being recalled in Canada due to product contamination that poses a safety risk. The recall affects all Canadian distributions of this medication. Co-Quetiapine is a prescription antipsychotic drug used to treat conditions like schizophrenia and bipolar disorder.

Reason

Contamination - Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2013-06-04

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/4a21085a-97df-43a7-89af-6de6a348123c